Alnylam tumbles on ALN-CC5 update

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) fell $7.98 (12%) to $60.81 on Tuesday after reporting that it will narrow its development program for paroxysmal

Read the full 222 word article

User Sign In